RxDoctor Payments Data

Kaitlin Baker, APRN

Psychiatric/Mental Health · McAlester, OKNPI 1396248456

Payments from drug & device makers

$725in general payments, 2019–2025

Across 23 payments — averaging $31.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$183
  • Alkermes, Inc.$150
  • Vanda Pharmaceuticals Inc.$101
  • Teva Pharmaceuticals USA, Inc.$86
  • Johnson & Johnson$81
  • Axsome Therapeutics, Inc.$55
  • plus $68 from 3 others

What the payments were for

  • Food & beverage$64489%
  • Education$8111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$725 in reported general payments places this provider in the 50th percentile of 231 psychiatric/mental health providers in Oklahoma.

See all psychiatric/mental health providers in Oklahoma

Medicare billing

Part B allowed, 2024
$12,840
Medicare patients
43
Services billed
160

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate14$117,809
AristadaAripiprazole Lauroxil21$66,874
Invega SustennaPaliperidone Palmitate24$60,622
VraylarCariprazine Hcl21$33,883
Duloxetine Hcl93$1,921
Bupropion XlBupropion Hcl61$1,487
Trazodone Hcl85$1,464
Aripiprazole52$1,413
Buspirone Hcl38$955
Perphenazine13$857
Quetiapine Fumarate76$848
Hydroxyzine Hcl40$763
Mirtazapine35$595
Venlafaxine Hcl ErVenlafaxine Hcl29$554
Risperidone33$396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada$150$66,87421 claims
Johnson & JohnsonInvega Sustenna$81$60,62224 claims
AbbVieVraylar$183$33,88321 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 231 psychiatric/mental health providers in Oklahoma.

Other psychiatric/mental health in McAlester

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →